Clinical Trial Update: Autologous Mesenchymal Stem Cells Transplantation in Thoracolumbar Chronic and Complete Spinal Cord Injury Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on autologous mesenchymal stem cell transplantation for chronic and complete thoracolumbar spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Hospital Sao Rafael | Conditions: Spinal Cord Injury | Phase 2 | Status: UNKNOWN